Voisin Consulting Life Sciences webinar icon
Webinar

Understand the Main CMC Challenges to Improve ATMP Development

Post thumbnail Understand the Main CMC Challenges to Improve ATMP Development

Recent clinical successes in cell therapy and gene therapy have shown how fast this field is advancing. While the clinical outcomes are leading the developments in this field, the chemistry, manufacturing, and control (CMC) are struggling to meet development needs, global regulatory compliance and timelines.

The intricacies of these advanced therapies represent many challenges. From cell source to the final product, sponsors are continuously addressing gaps to improve the product quality and deliver a safe and efficacious product. In this webinar, we will focus on the main CMC challenges in cell and gene therapy development in the EU and US and their integration as part of the overall product development.

Key takeaway message:

Present specific quality considerations for cell and gene therapies
Identify and take into account the CMC challenges during product development in order to minimize CMC hurdles
Provide insight on commonalities and differences between EU and US

Voisin Consulting Life Sciences download icon

Access the full webinar replay now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    Sample of the webinar

    Featured Speakers

    Alexandra Beumer Sassi
    Alexandra Beumer Sassi, PhD, RAC
    Senior Director, CMC
    As a Director, Chemistry, Manufacturing, and Controls (CMC) at VCLS, Alexandra (Alex) is responsible for providing CMC and regulatory consulting services to clients to help them take their…
    View profile
    François Gianelli thumbnail
    François Gianelli
    Director CMC & Quality
    As a CMC & Quality Director, François is involved in different projects for biologicals regulatory and CMC support. François is involved in authoring and reviewing CMC content (IMPD/IND and MAA/NDA/BLA), and performs gap-analysis of CMC development.